Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fifty Years of Research and One Conclusion: Opium Causes Cancer Publisher Pubmed



Sheikh M1, 2 ; Kamangar F3 ; Malekzadeh R2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer, World Health Organization, Lyon, France
  2. 2. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Biology, School of Computer Mathematical and Natural Sciences, Morgan State University, Baltimore, United States
  4. 4. Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Iranian Medicine Published:2020


Abstract

In September 2020, the International Agency for Research on Cancer (IARC) announced that opium consumption causes cancer in humans - a conclusion drawn after reviewing data from five decades of research. Given the widespread use of opium and its derivatives by millions of people across the world, the classification of opium consumption as a Group 1 carcinogen has important public health ramifications. In this mini-review, we offer a short history of opium use in humans and briefly review the body of research that led to the classification of opium consumption as carcinogenic. We also discuss possible mechanisms of opium's carcinogenicity and potential avenues for future research. © 2020 Academy of Medical Sciences of I.R. Iran. All rights reserved.
Related Docs
View other Related Docs
1. The Carcinogenicity of Opium Consumption: A Systematic Review and Meta-Analysis, European Journal of Epidemiology (2023)
2. Opium Use, Cigarette Smoking, and Alcohol Consumption in Relation to Pancreatic Cancer, Medicine (United States) (2016)
3. Mortality From Respiratory Diseases Associated With Opium Use: A Population-Based Cohort Study, Thorax (2017)
4. The Iranian Study of Opium and Cancer (Iropican): Rationale, Design, and Initial Findings, Archives of Iranian Medicine (2021)
5. Opium Use and Subsequent Incidence of Cancer: Results From the Golestan Cohort Study, The Lancet Global Health (2020)
6. Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer?, Archives of Iranian Medicine (2022)
7. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study, Cancer Epidemiology Biomarkers and Prevention (2018)
8. Opium Use and the Risk of Liver Cancer: A Case–Control Study, Cancer Prevention Research (2023)
Experts (# of related papers)
View all Related Experts
Reza Malekzadeh (54)
Hossein Poustchi (49)
Other Related Docs
9. Opiate and Tobacco Use and Exposure to Carcinogens and Toxicants in the Golestan Cohort Study, Cancer Epidemiology Biomarkers and Prevention (2020)
10. Impact of Opium on Bladder Cancer Incidence: A Systematic Review and Meta-Analysis; [Impacto Del Opio En La Incidencia Del Cancer De Vejiga: Revision Sistematica Y Metaanalisis], Actas Urologicas Espanolas (2025)
11. Opium Use and Risk of Lung Cancer: A Multicenter Case-Control Study in Iran, International Journal of Cancer (2023)
12. Prevalence and Clinical Outcomes of Common Bile Duct Dilation in Patients Who Use Opium, American Journal of the Medical Sciences (2018)
13. The Marginal Causal Effect of Opium Consumption on the Upper Gastrointestinal Cancer Death Using Parametric G-Formula: An Analysis of 49,946 Cases in the Golestan Cohort Study, Iran, PLoS ONE (2021)
14. Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran, International Journal of Epidemiology (2022)
15. Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma, Iranian Journal of Otorhinolaryngology (2017)
16. Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study, Gastroenterology (2019)
17. Evaluation of the Effects of Opium on the Expression of Sox2 and Oct4 in Wistar Rat Bladder, Bladder Cancer (2024)
18. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
19. Trends in the Incidence of Stomach Cancer in Golestan Province, a High-Risk Area in Northern Iran, 2004-2016, Archives of Iranian Medicine (2020)
20. Lead Poisoning Among Asymptomatic Individuals With a Long-Term History of Opiate Use in Golestan Cohort Study, International Journal of Drug Policy (2022)
21. Incident Cancers Attributable to Using Opium and Smoking Cigarettes in the Golestan Cohort Study, eClinicalMedicine (2023)
22. Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies, Frontiers in Nutrition (2020)
23. Cancer Incidence in the East Azerbaijan Province of Iran in 2015-2016: Results of a Population-Based Cancer Registry, BMC Public Health (2018)
24. Opium Use and the Risk of Cataract: A Hospital-Based, Group-Matched, Case–Control Study in Iran, Ophthalmic Epidemiology (2023)
25. Pars Cohort Study of Non-Communicable Diseases in Iran: Protocol and Preliminary Results, International Journal of Public Health (2017)
26. Association Between Incident Type 2 Diabetes and Opium Use: Mediation by Body Mass and Adiposity, American Journal of Epidemiology (2023)
27. Population Attributable Proportion and Number of Cancer Cases Attributed to Potentially Modifiable Risk Factors in Iran in 2020, International Journal of Cancer (2023)
28. Using Metabolomics to Investigate Biomarkers of Drug Addiction, Trends in Molecular Medicine (2018)
29. Prevalence and Determinants of Opioid Use Disorder Among Long-Term Opiate Users in Golestan Cohort Study, BMC Psychiatry (2023)
30. Opium Use and Risk of Colorectal Cancer: A Multi-Center Case-Referent Study in Iran, Acta Oncologica (2023)
31. Overexpression of Adiponectin Receptors in Opium Users With and Without Cancer, Clinical Pharmacology: Advances and Applications (2020)
32. Joint Effect of Diabetes and Opiate Use on All-Cause and Cause-Specific Mortality: The Golestan Cohort Study, International Journal of Epidemiology (2021)
33. Cancer in Iran 2008 to 2025: Recent Incidence Trends and Short-Term Predictions of the Future Burden, International Journal of Cancer (2021)
34. Dental Health and Lung Cancer Risk in the Golestan Cohort Study, BMC Cancer (2024)
35. Sensitivity of Self-Reported Opioid Use in Case-Control Studies: Healthy Individuals Versus Hospitalized Patients, PLoS ONE (2017)
36. Building Cancer Registries in a Lower Resource Setting: The 10-Year Experience of Golestan, Northern Iran, Cancer Epidemiology (2018)
37. Opium Consumption and the Incidence of Cancer: Does Opium Account As an Emerging Risk Factor for Gastrointestinal Cancer?, Journal of Gastrointestinal Cancer (2018)
38. Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures, Archives of Iranian Medicine (2021)
39. Associations Between Biomarkers of Exposure and Lung Cancer Risk Among Exclusive Cigarette Smokers in the Golestan Cohort Study, International Journal of Environmental Research and Public Health (2021)
40. Laryngeal Cancer in Iranian Women, Acta Medica Iranica (2023)
41. Impact of Opium Use on the Conventional Coronary Artery Risk Factors Among Outpatients in Afghanistan: A Case-Control Study in Andkhoy City, Pakistan Journal of Medical and Health Sciences (2021)
42. Causes of Premature Death and Their Associated Risk Factors in the Golestan Cohort Study, Iran, BMJ Open (2018)
43. Oral Embryonal Rhabdomyosarcom in an Adult Addict Man: A Case Report and Review of Literature, Journal of Kerman University of Medical Sciences (2021)
44. Opium As a Risk Factor for Early-Onset Coronary Artery Disease: Results From the Milano-Iran (Miran) Study, PLoS ONE (2023)
45. The Other Side of the Coin: Positive View on the Role of Opioids in Cancer, European Journal of Pharmacology (2022)
46. Pre-Diagnostic Risk Factors for Brain Cancer Incidence and Survival: Insights From the Golestan Cohort Study, BMC Cancer (2025)
47. Survival Assessment and Pre-Diagnostic Risk Factors for Lung Cancer Incidence: Insights From the Golestan Cohort Study, PLoS ONE (2025)
48. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period, International Journal of Cancer Management (2023)
49. Bladder Cancer Incidence in Iran: Results of the Iranian National Population-Based Cancer Registry From 2014 to 2016, Urology Journal (2022)
50. Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran a Cross-Sectional Analysis, Medicine (United States) (2016)